{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreic5aeupbdtwopdzxz7mqstu7utmqpc2lhvzbavh2ozuhf27q3g3km",
    "uri": "at://did:plc:73txmnzc4imhrv5q7azno3up/app.bsky.feed.post/3mkbikofguor2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie7zenn3cprtim4yopid4zj7ixelwcf3pduxpguzjx7pi6mrdighm"
    },
    "mimeType": "image/jpeg",
    "size": 39678
  },
  "path": "/news/science/166533-russia-oncovaccine-melanoma-lung-pancreatic-cancer/",
  "publishedAt": "2026-04-24T20:51:00.000Z",
  "site": "https://english.pravda.ru",
  "tags": [
    "Science"
  ],
  "textContent": "The experimental cancer vaccine developed by the Gamaleya Research Center will be used to treat several types of cancer, Alexander Gintsburg, the director of the center said.\nFocus on High-Mutation Cancers\n\nAccording to Gintsburg, melanoma and lung cancer contain the highest number of mutations, making them primary targets for this therapeutic approach.\nThe next stage in the development of cancer treatment will focus on non-small cell lung cancer, which remains one of the most challenging forms of the disease.",
  "title": "Russia Develops Cancer Vaccine to Treat Multiple Tumor Types"
}